Effect of High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Respiratory distress syndrome (RDS) in preterm babies is caused by a deficiency of lung surfactant. The risk of RDS increases with decreasing gestational age, and is almost inevitable in babies born at less than 28 weeks gestation. Without surfactant the lungs become stiff and the alveoli collapse at end-expiration, and untreated RDS is a major cause of morbidity and mortality in preterm infants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2023
CompletedFirst Posted
Study publicly available on registry
May 8, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedMay 8, 2023
May 1, 2023
1 year
March 24, 2023
May 5, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
The rate of invasive mechanical ventilation at the first 72 hours of life.
Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the need for invasive mechanical ventilation at the first 72 hours of life.
first 72 hours of life
Time for weaning off from oxygen.
Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the time for weaning off from oxygen.
Baseline
Duration of hospital stay.
Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the duration of hospital stay.
Baseline
Rate of morbidity and mortality.
Regarding the following aspect: The effect of high flow nasal cannula versus CPAP on the clinical outcomes of preterm infants with respiratory distress syndrome regarding the effect on morbidity and mortality.
Baseline
Study Arms (2)
High flow nasal cannula
preterms infants who are connected to high flow nasal cannula
Continuous positive airway pressure
preterms who are connected to continuous positive airway pressure
Eligibility Criteria
100 preterm infants between 30 weeks and 37 weeks
You may qualify if:
- Preterm infants ≥30 weeks
- Preterm infants with birth weight \>1000 gm
- Preterm infants diagnosed with respiratory distress syndrome.
You may not qualify if:
- Full term infants (\>37 weeks)
- Preterm infants (\<30 weeks \& less than 1000 gm)
- Neonates with respiratory distress other than respiratory distress syndrome.
- Neonates with neonatal sepsis.
- Neonates with congenital anomalies including congenital heart diseases.
- Neonates who need invasive MV immediately after birth.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gafar Ibrahim, Prof
Assiut University
- PRINCIPAL INVESTIGATOR
Safwat Moahmed, Assist prof
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 24, 2023
First Posted
May 8, 2023
Study Start
June 1, 2023
Primary Completion
June 1, 2024
Study Completion
August 1, 2024
Last Updated
May 8, 2023
Record last verified: 2023-05